Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
IQMD was delisted on the 26th of April, 2023.
58 hedge funds and large institutions have $161M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 7 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 4
5% more capital invested
Capital invested by funds: $154M → $161M (+$7.5M)
0% more funds holding
Funds holding: 58 → 58 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.2M |
| 2 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$1.12M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$1.05M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.01M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$987K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$4.01M |
| 2 |
JP Morgan Chase
New York
|
-$1M |
| 3 |
ECU
Eisler Capital (UK)
London,
United Kingdom
|
-$803K |
| 4 |
KC
Kryger Capital
London,
United Kingdom
|
-$421K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$384K |
IQMD Hedge Fund Activity: Q3 2022 in Review
58 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q3 2022, worth a combined $161M — up 4.9% from $154M a quarter earlier.
Fund positioning in IQMD was balanced in Q3 2022: 7 funds opened new positions, 7 closed out, 18 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, adding an estimated $4.2M. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $4.01M sold.
- 58 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $161M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q3 2022, up 4.9% quarter-over-quarter.
- 7 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q3 2022 and 7 closed out, a net change of 0 holders.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q3 2022 was Millennium Management, an estimated $4.2M added.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q3 2022 was Cantor Fitzgerald, an estimated $4.01M sold.
Based on aggregated 13F filings for Q3 2022.